Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
- Sponsor
- University Medical Center Groningen
- Study ID
- NCT06647602
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Differentiated Thyroid Cancer
- Levothyroxine
- Liothyronine
- Thyroid Cancer
- Thyroid Hormones
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Euthyrox (levothyroxine) — DRUGEuthyrox (levothyroxine sodium tablets; L-T4) is a thyromimetic synthetic drug identical to T4. Patients will recieve levothyroxine (euthyrox) in a dose of 2 μg × kg body weight / day.
- Cytomel (liothyronine) — DRUGCytomel (liothyronine sodium tablets; L-T3) is a thyromimetic synthetic drug identical to T3. The patients in this cohort recieve L-T4+L-T3 combination therapy. The L-T4 dose will be 2 μg × kg body weight / day, equal to the dose in the other interventional arm. L-T3 will be added twice daily from the first day of combination treatment, in dosages gradually decreasing from 25 ug 2/day to 5 ug 2/day over a time span of 3 weeks after which L-T3 is stopped.
Study Details
This study will be a multicentre prospective cohort study on TH-substitution after thyroid hormone withdrawal preceding radioiodine treatment.
Key Dates
- First listed
- Oct 18, 2024
- Start date
- Sep 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Mar 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: TH-combination cohortL-T4+L-T3 combination according to local protocol.
- Arm: Levothyroxine cohortL-T4 monotherapy according to local protocol.
Primary Outcome Measure
TSH after two weeks of TH substitution [ Time Frame: Before and after 2 weeks of TH-substitution ]
Central Contacts
- Mirthe Links, BSc+31 50 3610973
- Wouter Zandee, MD/PhD+31 50 3613731
Related Studies
- Studies on Tumors of the ThyroidRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Hereditary Risk Factors for Thyroid CancerRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California